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Abstract 
This project studies and compares the removal effectiveness of three ion-exchange resins 
and granular activated carbon (GAC) on aqueous solutions of sulfamethoxazole (SMX) at pH 5, 
7, and 9. After treatment by adsorption, the final concentration of SMX was measured with a UV 
spectrophotometer. Evaluation of adsorbent effectiveness included the analysis of kinetics and 
equilibrium data. Results yielded that Filtrasorb 200, Marathon and Optipore worked most 
successfully due to chemical structuring and specific adsorption characteristics. Experiments also 
indicated that pH level did not significantly affect the adsorbent effectiveness. 
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Chapter 1: Introduction 
Over the past decade, the demand for pharmaceuticals and personal care products 
(PPCPs) has nearly paralleled the escalating population. The pharmaceutical industry has 
expanded to accommodate for this need, producing hundreds of tons of synthetic chemicals per 
year (Pontius, 2002) and growing by nearly $500 billion in the world market between 2003 and 
2011 (IMS, 2012). The prolonged use of PPCPs has led to evident emergence in the 
environment, creating the potential for adverse consequences to ecosystems and human health. 
The rise in both contamination and consumption of natural resources spurs the need to protect 
what we have for future generations. 
PPCPs, despite years of persistent usage, have become a contemporary concern because 
of their widespread occurrence in the environment and their correlation to ecological 
disturbance. PPCPs encompass a diversity of chemicals found in veterinary medicine, 
agricultural practice, human health and cosmetic care. Traces of these chemicals in both aquatic 
and terrestrial domains, found in low concentrations ranging from nanograms to micrograms per 
liter (ng/L – µg/L), have only been confirmed within the past decade due to recent improvements 
in chemical analysis. New technology and methodologies have allowed for the execution of 
necessary studies, such as those involving the transport of PPCPs in the environment. The origin 
and fate of PPCPs varies widely, depending on discharge locality, present treatment, and 
chemical reactivity. However, the chemical transport of PPCPs is still chiefly unknown. On the 
other hand, it is known that there are multiple pathways to the environment, especially into water 
bodies. 
In particular, antimicrobials and their metabolites are appearing in significant amounts in 
water supplies. Although no evidence exists that human health is affected by minute doses of 
antibiotics over long periods of time, changes have been observed in ecosystem functions. 
Studies have determined a rising level of antimicrobial-resistant organisms in the environment. 
In addition to antimicrobial resistance, the bacteria being studied displayed a delay in cell 
growth, limited denitrification, and shifts in community composition (USGS, 2012). 
Antimicrobials, like most PPCPs, enter ecosystems by improper disposal, excretion, and 
wastewater effluent discharges. The majority of these frequently-used compounds and their 
metabolites are not completely removed by treatment systems, with removal efficiencies reported 
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between zero and 90% (Bhandari et al., 2008). Because of increased usage rate, lack of efficient 
removal technology, and environmental risks associated with PPCP occurrence, there is reason to 
develop new materials and processes in treatment systems in order to eliminate antibiotics from 
entering the environment. 
A class of antimicrobial drugs commonly found in wastewater effluent is sulfanilamides. 
These compounds are a subset of chemicals containing the sulfonamide functional group, to 
which numerous prescription drugs belong. Sulfonamide drugs consist of anti-diabetic agents, 
anticonvulsants, diuretics, protease inhibitors, and beta-blockers. These compounds are of 
concern due to their expansive use and inability to readily biodegrade in the environment, despite 
the fact that many sulfonamides are photodegradable in surface waters (Niu et al., 2012). 
Sulfanilamide antimicrobials interfere with microbiological mechanisms by mimicking essential 
bacterial enzymes, making the compounds possibly detrimental to secondary wastewater 
treatment processes. 
Sulfamethoxazole (SMX), a broad-spectrum biostatic sulfanilamide, has become a point 
of interest because of its prevalence in contaminated wastewaters at concentrations correlated to 
bacterial resistance and genetic mutations in organisms (Niu et al., 2012). Figure 1 shows the 
chemical structure of SMX. Although therapeutically active by itself, SMX is often paired with 
trimethoprim (TMP), creating a synthetic antibacterial combination drug that affects the 
biosynthesis of nucleic acids and proteins in bacteria. The SMX-TMP drug is one of the most 
highly prescribed antibiotics for treating bladder, lung, and ear infections. Sulfa allergies and 
liver toxicity pose as common side effects in consumers of this antibiotic. The human body does 
not fully metabolize the compound, causing about 30% to be excreted in its original 
pharmaceutically active form.  
 
Figure 1: Molecular Structure of Sulfamethoxazole (Source: US FDA, 2012) 
 
Taking into account the widespread use of sulfonamides and their potential 
environmental effects, there is importance in developing new technologies for removing SMX 
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and similar compounds from points of discharge. Current water and wastewater treatment 
processes, such as advanced oxidation, photolysis, and adsorption by granular activated carbon 
(GAC), have shown some success in the removal of SMX. UV-light treatment has exhibited 
promising results because the aforementioned photosensitivity. In addition, research has been 
conducted on the effectiveness of high-silica zeolite adsorbents and GAC at various pH levels. 
Despite research with a variety of current technologies, the compound is still not entirely 
degraded or removed, having been found at alarming concentrations in surface water, 
groundwater, and soils (Bhandari et al., 2008). However, there are up-and-coming adsorbents, 
particularly ion-exchange resins, which have not been fully researched in SMX removal.  
This project aims to analyze the removal effectiveness of ion-exchange resins on aqueous 
solutions of SMX in water at pH levels of 5, 7, and 9. In order to carry out this analysis, the team 
determined specific resins to be studied based on adsorbent properties, commercial availability 
and professional recommendations. The chemical properties and current removal technologies 
for SMX were researched to find adsorbents best suited for potentially removing the compound. 
Methods pertaining to adsorption as treatment were also researched in order to help tailor the 
experimental procedures to the resins studied in this project. Moreover, the removal efficiency of 
the ion-exchange resins was compared to that of Filtrasorb 200®, a brand of GAC, in order to 
close gaps encountered in previous research. 
 
  
4 
 
Chapter 2: Background 
 This chapter will provide an overview of research concerning the environmental 
presence, risks, and current treatments for SMX. In order to establish a perspective on the 
potential consequences of SMX in the environment, the chapter opens with a summation of 
PPCPs and the effects of their occurrence. The next section introduces the chemical structure, 
pharmacological properties, and the usage of SMX. Following the synopsis of its properties is a 
review of its occurrence along with a discussion focusing on associated environmental risks, 
including bacterial resistance and genetic mutations. A brief background of advanced oxidative 
processes is provided to acknowledge successful treatments in the removal of SMX. The last 
section details the adsorption treatment process, which is employed as a means of removing 
SMX in this project. 
2.1 Pharmaceutical and Personal Care Products in the Environment 
 The development of PPCPs and pharmaceutically active compounds (PhACs) over the 
past century has drastically changed healthcare and world industries. This diverse group of 
chemicals is typically used in agriculture, veterinary medicine, human health, and cosmetic care 
(Daughton, 2004). However, decades of manufacturing, consumption, and disposal of these 
compounds have caused eminent damage in ecosystems and human health. Alongside the 
environmental issues pertaining to synthetic chemicals, the increasing population has triggered a 
corresponding trend in the consumption and pollution of water supplies, necessitating the 
implementation of new treatment technologies and environmental laws.  
 Research over the past 30 years has indicated ecological effects related to the emergence 
of PPCPs. Antibiotics, steroids, detergents, antidepressants, and pesticides consist of a few of the 
chemicals initially linked to environmental pollution. These chemicals have been found to both 
directly and indirectly interact with hormone receptors in organisms (Daughton, 2004). Those 
substances, defined as endocrine disrupting compounds (EDCs) by the United States 
Environmental Protection Agency (EPA), alter the balance of hormones responsible for 
developmental processes and homeostasis. Issues with synthetic chemicals were noticed before 
major research on EDCs began. A well-known case of these observations was documented with 
the 1962 publishing of Rachel Carson’s Silent Spring, which described the decline in bird 
population in an area sprayed with DDT. Since then, studies have shown connections between 
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PPCP prevalence and aquatic toxicity, irregularity in ecological communities, and antibiotic 
resistance (USGS, 2012). These substances tend to be detected at low concentrations (ng/L – 
µg/L) and occur in a variety of climatic, hydrological, and land-use settings for long periods of 
time (Boxall et al., 2012). Despite the outcomes of these studies, the fate and transport of PPCPs 
is still unknown due lack of long-term investigation and appropriate chemical analyses. 
Furthermore, there is little evidence confirming the effects on human health from continual 
exposure to trace concentrations of these substances. The potential for harm to health still exists, 
since the combination of therapeutic doses of pharmaceuticals can generate adverse interactions 
(Boxall et al., 2012). 
 Although the exact fate and transport of PhACs is unclear, research provides an 
understanding of their pathways into the environment. Awareness of these pathways aids in the 
development of source and pollution control. Both PPCPs and PhACs enter aquatic and 
terrestrial domains by multiple entries, as illustrated in Figure 2.  
 
 
Figure 2: Pathways of PPCPs into environment. (Source: Boxall et al., 2012) 
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While hospitals and manufacturing facilities are significant sources of PhACs, municipal 
wastewater treatment plants (WWTPs) contribute the greatest amount of such into groundwater 
and surface waters (Bhandari et al., 2008). Major sources of substances to wastewater influent 
include improper disposal of medicines and excretion of metabolized drugs. Reports show some 
removal of PhACs during WWTP processes, but removal efficiencies range from zero to 90% 
and do not indicate either the exact removal or the chemical transformation of the parent 
compound (Bhandari et al., 2008). Considering the occurrence of pharmaceuticals and their 
known effects, there are risks associated with the incomplete removal of these compounds. 
In particular, there are concerns about the presence of antibiotics in WWTPs and the 
degradation processes in septic systems. Like many PhACs, a number of antibiotics are not 
readily degradable in the environment and have a direct effect on microbial and ecological 
functions. Antimicrobials have been shown to cause bacterial resistance, which may affect the 
sorption of PPCPs to activated sludge treatment (Boxall et al., 2012). In turn, antimicrobials may 
be transformed into toxic oxidation products. Groundwater is most vulnerable to the persistence 
of antibiotics because of the absence of sunlight to photodegrade the contaminants (Underwood 
et al., 2011). The natural attenuation of antimicrobials in groundwater establishes the potential to 
cause adverse impacts on aquifer bacteria and associated ecosystem functions. Taking into 
account the known outcomes of antimicrobial occurrence, developments of new technologies are 
crucial in reversing the possible detrimental effects in water supplies. 
2.1.1 Sulfonamides 
One class of PhACs that is a growing environmental concern is sulfonamides, more 
commonly known as “sulfa” drugs (Bhandari et al., 2008). These particular pharmaceuticals 
have a molecular structure that contains a central sulfur atom belonging to a sulfonyl group and 
adjoins characteristic amine groups. Sulfonamides cover a wide spectrum of therapeutic 
substances: anti-diabetic agents, anticonvulsants, diuretics, protease inhibitors, and beta-
blockers. Other applications include agricultural antibiotics (Sedlak et al., 2005).  
Sulfanilamides, a subcategory of sulfonamides, encompass a family of antimicrobials containing 
the sulfonamide functional group attached to a characteristic aniline unit (PubChem, 2005). This 
project focuses on the removal of one such sulfanilamide, sulfamethoxazole (SMX), by ion-
exchange resins and adsorbents. 
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2.2 Sulfamethoxazole  
 SMX belongs to the sulfanilamide drug class as a wide-spectrum bacteriostatic 
antimicrobial. This polar, UV-light-sensitive chemical is typically combined with trimethoprim 
(TMP) to form a more effective antibiotic commonly known by brand names such as Bactrim®, 
Septra®, and Gantanol®. The SMX-TMP combination drug inhibits two crucial steps in the 
biosynthesis of folic acid in bacteria, limiting bacterial reproduction. The antimicrobial, one of 
the most frequently prescribed in the world for bladder and lung infections, works against gram-
negative and gram-positive aerobic bacteria, including Escherichia coli, Streptococcus, and 
Staphylococcus aurea. In spite of its high dispense rate, SMX frequently causes severe reactions, 
such as anaphylaxis, rash, and Stevens - Johnson syndrome (US FDA, 2008). 
 
 
Figure 3: Molecular Structure of Sulfamethoxazole (Source: US FDA http://www.fda.gov) 
 
Figure 3 shows the basic molecular arrangement of SMX (C10H11N3O3S). The molecule 
is structured with a sulfonyl group, connected to an amine group to the right and an aniline group 
to the left. The compound acts as an analog to para-aminobenzoic acid (PABA) in the bacterial 
production of folic acid. In the combination SMX-TMP antibiotic, SMX blocks the first step in 
the synthesis by competing with PABA, hindering the production of dihydrofolic acid. TMP 
affects the second step by binding to dihydrofolate reductase, an enzyme essential to the 
production of tetrahydrofolic acid (US FDA, 2008). After absorption in the human body, SMX is 
excreted in its original form (approximately 30%) as well as two metabolites, N4-acetyl-SMX 
and SMX-N1-glucuronide (Radke et al., 2009).  
 At standard temperature and pressure, SMX exists in solid form as yellow-white powder 
or crystals with a molecular weight of 253.28 grams per mole. In neutral form, it has a melting 
point of 166 °C and is poorly soluble in water. SMX exhibits acid/base characteristics, appearing 
in ionic and neutral forms corresponding to pKa values of 1.7 ± 0.1 and 5.64 ± 0.07 (Knappe et 
al., 2007). Figure 4 illustrates the acid-base speciation of SMX. 
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Figure 4: Acid-Base Dissociation Equilibrium of SMX (Source: Xekoukoulotakis, 2011) 
 
SMX predominantly occurs in its neutral form, appearing in relatively acidic solutions 
where its pKa value (5.64 ± 0.07) corresponds to the average pH level of surface water. Since the 
pH in surface water falls between 5 and 9, the negatively-charged form of SMX also appears 
often (USGS, 2012). The aniline group on the molecule has a negative charge on the nitrogen 
atom, which acts as an ionic binding site. SMX rarely exists in its protonated form, which 
requires an extremely acidic setting. The variance in pH throughout WWTP processes and the 
environment causes the charge on SMX to change, which may allow for successful removal by 
ion-exchange sorption. 
2.3 Sulfamethoxazole in the Environment 
The expanding production and consumption of antimicrobials are correlated to their 
frequent occurrence in water supplies. Antimicrobials enter water bodies via several pathways, 
with the main routes of release being improper disposal and human excretion (Bandari et al., 
2008). The widely-used antibiotic SMX recurs in water supplies and WWTP effluent for these 
reasons. Corresponding to its demand and environmental prevalence are emerging issues with 
bacterial resistance and toxicity in aquatic organisms. 
2.3.1 Prevalence in Aquatic Systems 
 Research indicates that SMX is among the most ubiquitous antimicrobial contaminants in 
the aquatic domain. Surface waters, groundwater, drinking water, and wastewater effluents all 
have been found to contain traces of SMX. Recent technological improvements in chemical 
analysis and detection methods have allowed for the detection of low SMX concentrations and, 
in turn, for these studies to take place.  
A study by Bhandari et al. (2008) evaluated the occurrence of several widely prescribed 
antibiotics, including SMX, in municipal WWTPs. Effluent samples were taken over the course 
of a year from four facilities, all of which utilized activated sludge systems, in the Midwestern 
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United States. The treatment capacities among the sampled facilities ranged from 3 million to 80 
million liters per day. From two of the smaller facilities, influent and effluent SMX 
concentrations averaged 18.3 ± 10.6 µg/L and 3.25 ± 5.49 µg/L, respectively. Other WWTP 
effluents reported outside the Bhandari study have detected concentrations between 0.21 and 7.9 
µg/L. The Bhandari study observed a seasonal variability in SMX concentrations. According to 
the analysis, SMX effluent concentrations are much lower in the summer than in the winter, but 
the opposite holds true for contaminated influent.  
Another study revealed the prevalence of SMX in groundwater (Underwood et al., 2011). 
In a nationwide groundwater survey conducted by the United States Geological Survey (USGS), 
SMX appeared in 23% of the samples at an average concentration of 1.11 µg/L. The study also 
mentions the presence of SMX in contaminated waters globally, reporting concentrations 
between 0.25µg/L and 68µg/L. This publication also states that there are high occurrence rates of 
SMX in groundwater from a sandy drinking-water aquifer on Cape Cod, MA. The variance in 
SMX concentrations suggests that, while there is natural attenuation of SMX in surface waters 
and evidence of reduction in WWTPs, the persistent low concentrations of SMX may inhibit 
ecosystem health in groundwater. 
The 2005 publication “Occurrence Survey of Pharmaceutically Active Compounds” 
reported a wide range of SMX concentrations from various sources (Sedlak et al., 2005). In the 
survey, an evaluation of PhAC concentrations was conducted on engineered treatment wetlands, 
effluents from conventional and advanced WWTPs, and the Sweetwater soil aquifer treatment 
system. SMX was found in over 50% of samples collected from wastewater effluent and surface 
water (Table 1.8: “Summary of occurrence data for antibiotics”, p. 23). The highest 
concentrations detected in conventional WWTPs were a result of SMX presence, ranging from 
60 to 2000 ng/L (0.06 to 2 µg/L). High concentrations of SMX also appeared in samples from 
the Mt. View engineered treatment wetland and in shallow well samples from the Sweetwater 
soil aquifer treatment system. 
2.3.2 Risks to Environment and Human Health 
 As an antibiotic, SMX is often associated with antibacterial resistance, but its risks to 
ecological systems and human health extend beyond this typical issue. Examples of these issues 
are alterations to the balance of naturally-occurring microorganisms, the nitrogen cycle, genetic 
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mutations, and aquatic toxicity. The following studies validate the current and potential risks 
correlated to the environmental occurrence of SMX.   
The previously mentioned 2011 publication on a nationwide groundwater survey 
describes the effects of SMX on bacterial enrichment (Underwood et al., 2011). In the 
experimental portion of the survey, an enrichment culture prepared with groundwater samples 
taken from a Cape Cod drinking-water aquifer were exposed to environmentally relevant 
concentrations of SMX. Experimental findings concluded that SMX delayed cell growth, 
decreased nitrate reduction rate potentials, and caused genetic interference in Pseudomonas soil 
bacteria. These findings suggest that ecological exposure to SMX directly affects the nitrogen 
cycle by decreasing bacterial metabolic ability of nitrogen, which, in turn, increases NO3 
concentrations. This is a concern because NO3 contamination in drinking water is related to 
serious health disorders such as methemoglobinemia. 
Antimicrobial resistance is one of the prominent environmental concerns correlated to 
SMX. The concentrations found in WWTP effluent and surface waters are equivalent to the 
minimum inhibitory concentrations (MICs) of bacteria. MICs estimate the susceptibility of 
bacteria to antimicrobials. According to the 2012 US FDA data sheet for Bactrim®, MICs for 
susceptibility of Enterobacteriaceae family of pathogens are less than 20 µg/L (US FDA, 2012). 
Long-term bacterial exposure to this concentration allows for genetic mutations contributing to 
bacterial resistance (Pruden et al., 2006). In addition to bacterial mutations, SMX has exhibited 
biotoxicity for fish and algae growth, having caused genetic mutations and chronic effects (Niu 
et al., 2012). 
2.4 Treatment Technologies 
2.4.1 Advanced Oxidation Treatments 
Oxidation 
In the process of ozonation, ozone (O3) gas is generated by running a current through O2 
gas. The O3 is then bubbled through liquid containing the compound to be removed. Because O3 
is unstable, it decomposes into O2 and an oxygen radical. In ozone treatments on SMX, this free 
radical is attracted to available hydrogen on the organic structure of SMX.  
The use of ozonation in water treatment constitutes advantages and disadvantages. As an 
advantage, the resulting by-products of ozonation are smaller and easier to be biodegraded. This 
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is especially desirable when there is a high concentration of complex organic carbons in the 
water. On the other hand, molecular ozone also oxidizes naturally-occurring bromine atoms. The 
resulting bromate is difficult to remove from water and is strongly suspected of being a 
carcinogen. As a result, bromate concentration in water is regulated and must be kept below 10 
µg/L (Viessman et al, 2009).  
UV Photolysis 
UV Photolysis is an advanced oxidation process (AOP) in which energy from ultraviolet 
light (100 < λ < 400 nm) strikes a molecule and breaks bonds. Most times, this occurs in the 
presence of a catalyst. The extent of dissociation depends on the contact time and the intensity of 
the UV rays. The reaction can be enhanced using H2H2. However, like ozonation, UV photolysis 
may result in disinfection by-products, which can have variable toxicity. 
Chlorination 
 Chlorine disinfection is the most common disinfection method in water and wastewater 
treatment in the United States. It is used for both primary and secondary disinfection as free and 
combined chlorine. Free chlorine in particular has been shown to be effective in the treatment of 
SMX, reacting with the neutral and anionic forms of SMX (García-Galán et al., 2008). However, 
this results in the formation of byproducts. Those byproducts may not show up in a measurement 
of UV absorbance because of a change in structural characteristics (Radjenovic et al., 2009).  
Additionally, the treatment reactions must take place in excess of free chlorine in order to 
maintain treatment. One of the chlorination products, N-chlorinated SMX, was found to yield the 
parent SMX in the absence of reducing agents, or when there is no significant excess of free 
chlorine, within hours (Dodd and Huang, 2004). Because of this, chlorination treatment of SMX 
requires excessive disinfectant and is not as effective overall. 
2.4.2 Adsorption and Ion Exchange 
This project focuses on the use of adsorption, a key stage found in water treatment 
processes, to remove a polar compound from water. Adsorption is the accumulation of molecules 
on the interface of phases, commonly being either gas-solid or liquid-solid. Adsorbents have an 
adhesive energy greater than the cohesive energy of the adsorbate. Activated carbon, silica gel, 
activated alumina, and aluminosilicates are among the most common adsorbents. The adsorbents 
used in this study were chosen based on potential removal effectiveness for the adsorbate, SMX. 
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In general, the polarity, molecular size, characteristics of the solvent, and the functionality of 
adsorbate determine the proper adsorbents to use.  
The mechanisms behind adsorption involve weak and reversible molecular bonds, 
allowing for adsorbent regeneration and adsorbate extraction. Van der Waals forces, steric 
interaction, hydrogen bonds, hydrophobicity and polarity are some of the mechanisms associated 
with adsorption, which can be categorized by two basic types: physical adsorption and 
chemisorption (Chiou, 2002). Physical adsorption, the type that entails van der Waals forces, 
does not require functional sites on a surface and generates multilayer accumulation. 
Chemisorption, which generates single-layer accumulation, involves chemical bond forces and 
requires functional sites within the adsorbent in order for bonds to form. Often times, there is a 
combination of the two types, since adsorption energies vary among different substances being 
adsorbed and the materials to which they adhere (Chiou, 2002). In addition to the types of 
bonding, the adsorption process involves thermodynamics such that there is a reduction in 
freedom of molecular motion that causes a loss in system entropy.  
Ion exchange, although not formally recognized as adsorption, is a sorption process in 
which ions in solution are transferred to a solid matrix containing ions of similar polarity 
(Armenante, 1999). This process differs from adsorption because it requires an interchange of 
materials for the purpose of maintaining electroneutrality. No chemical alterations take place to 
either the adsorbent or the contaminant, but regeneration is required to replace the ions adsorbed. 
This process works well on organic compounds and ionized substances that are small in 
molecular size, as size affects the charge density of the molecule and the ion exchange rate 
(Armenante, 1999). When removing organic compounds, ion exchangers tend to act more as 
conventional adsorbents. As a process overall, ion exchange is practical because of its handling 
capacity and its ability to recover expensive materials, concentrate pollutants, and be 
regenerated. 
Factors Affecting Adsorption 
 The rate of adsorption changes according to adsorbent and adsorbate characteristics, such 
as surface area, particle size, solubility, and pH (Armenante, 1999). The surface area of the 
adsorbent plays a role in adsorption capacity, with larger sizes implying greater capacity. Smaller 
adsorbent particle size increases adsorption capacity since it reduces limitations on internal 
diffusional and mass transfer. The solute, or adsorbate, also affects this process, depending on its 
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solubility in liquid, affinity for the adsorbent, ionization, and molecular size compared to the 
adsorbent pore size. In addition to the structural and physical aspects of the materials involved, 
this process is contingent on other factors such as contact time and pH. Temperature has one of 
the greater impacts on the extent of adsorption (McCabe et al., 2005). 
 Several of the aforementioned attributes posed as critical parameters in determining 
potential adsorbents for SMX. These parameters included pore size, specific surface area, and 
loading capacity. Other attributes covered adsorbent functional groups, structure, and 
compatibility with neutral and anionic forms of SMX. 
Granular Activated Carbon 
The granular activated carbon (GAC) evaluated in this project was Filtrasorb® 200 (FS-
200), manufactured by Calgon Carbon Corporation. The product data sheet is shown in 
Appendix D. GAC falls under the larger of two sizes in activated carbons, which are the most 
commonly used adsorbents in wastewater treatment (Armenante, 1999). The smaller size, 
powdered activated carbon (PAC), is produced for direct addition to small amounts of 
wastewater and is characteristically small in particle size (<200 mesh). GAC, often used in 
adsorption columns, is comprised of reagglomerated coal-based activated carbon and has a high 
specific surface area with a particle size range of 0.4 to 2.5 mm. Activated carbons have a 
complex pore structure ranging in diameters from 10 to 10,000 Å, enabling a diversity of 
molecules to adsorb to the surface. Micropores, or pores having a diameter smaller than 1000 Å, 
are the key adsorption locations in activated carbon (Armenante, 1999).  
Ion Exchange and Polymeric Resins 
An application that has not been significantly studied for SMX removal is ion exchange 
with resins. Ion-exchange resins are small porous plastic beads with polystyrenic matrix 
structures that contain permanently attached, or fixed, ions (De Dardel, 2010). Free-moving 
counterions are integrated into the resin to neutralize the fixed ions. Fixed ions contain the 
functional groups that attract the solute, which in turn are exchanged for the mobile counterions. 
Figure 5 shows the basic structure of cation and anion resin beads. Functional groups can be seen 
attached to the skeleton, whereas the counterions fill the available spaces in the resin. 
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Figure 5: Schematic cation and anion resin beads (Source: http://dardel.info) 
The polystyrenic matrix of a resin is composed of styrene monomers in cross-linked 
chains. Resins are activated for different types of ion exchange reaction, which generally falls 
under one of the following: strongly acidic cation, weakly acidic cation, strongly basic anion, 
and weakly basic anion. Some resins are not classified as ion-exchange, but they act similarly 
due to the chemical nature of their unique structures (De Dardel, 2010). Strongly acidic cation 
exchange resins are activated via sulphonation, producing hydrogen as the exchange ion. Weakly 
acidic cations involve the hydrolization of carboxylic acid groups in acrylic polymers. Both 
strongly and weakly basic anion exchange resins are formed from a two-step process, which 
requires chloromethylation followed by animation, or the replacement of a covalent chloride by 
an amine (De Dardel, 2010). Other polymeric resins act as chelates, which surround adsorbates 
in a claw-like formation. 
One polymeric resin identified as potentially 
effective was Amberlite® XAD4 (AMB), an 
industrial grade cross-linked polymeric adsorbent 
manufactured by Dow Chemical Company. This 
adsorbent comes in the form of white insoluble 
beads and tends to remove organic substances with 
low molecular weight. Although non-ionic, its 
macroreticular aromatic structure enables the 
adsorption of hydrophobic molecules from polar solvents. Its structure, shown in Figure 6, 
contains a continuous polymer and pore phase, yielding a high surface area and broad micropore 
distribution. The engineering data sheet for AMB is shown in Appendix D. 
Figure 6: Amberlite XAD4 molecular structure 
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Another resin that was analyzed in this study is DOWEX Marathon® C (MAR), a 
uniform particle size, high capacity cation exchange resin used in demineralization and softening 
applications. Its small and uniform particle size enables efficient regeneration, kinetics, and 
higher operating capacity. MAR is produced as amber translucent spherical beads that contain 
styrene-DVB matrices, with sulfonic acid as the functional group. Because of its high acidity, the 
resin requires a rinse before application. Appendix D contains the product data sheet for MAR.  
Lastly, Optipore® L493 (OPT) was studied. OPT is a highly cross-linked polymeric resin 
that has a hydrophobic surface and contains no functional group. This resin has a high surface 
area and a broad pore size distribution of 20 to 50 mesh, which concentrates organic compounds. 
OPT regeneration includes several methods, such as steam and water rinse, and depends on the 
nature of the adsorbate. The OPT product information sheets are found in Appendix D. 
Isotherms 
 Adsorption effectiveness can be changed by numerous factors, such as temperature, 
contaminant polarity, and pH. By studying adsorption at equilibrium conditions, a relationship 
can be developed between the remaining concentration of the contaminant and the amount of 
contaminant adsorbed. Adsorption isotherms express this graphically by plotting equilibrium 
concentration against the mass of the contaminant removed per mass adsorbent.  
Different types of isotherms portray different efficiencies of an adsorbent at removing a 
given contaminant. Two typical adsorption isotherm models are the Freundlich and Langmuir 
isotherm equations, which model different behaviors of data and their appropriate applications. A 
linear isotherm goes through the origin of the graph and occurs when the amount of contaminant 
removed is directly proportional to the concentration left in solution (McCabe et al., 2005). 
Favorable isotherms are shown graphically as being convex up, and unfavorable isotherms are 
concave up (McCabe et al., 2005). Irreversible isotherms describe adsorption in which the 
concentration has no impact on the amount of substance adsorbed and in which desorption must 
be performed at significantly higher temperatures than other isotherms. 
Freundlich Model 
 The Freundlich isotherm is described using an empirically derived equation that portrays 
strongly favorable adsorption. Developed by Herbert Freundlich in 1926, this equation often 
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better fits data from liquid-solid adsorption (McCabe et al., 2005). Equation (1) displays the 
Freundlich equation. 
       
 
 
 
 
       (1) 
In the Freundlich equation, qe is the ending loading rate, Ce is the ending concentration in 
solution, and Kf and n are constants. Kf is an equilibrium constant based on the y-intercept of the 
data trendline on a log-log graph, and n the reciprocal of the slope of the trendline.   
Langmuir Model 
 In contrast to the Freundlich isotherm, the Langmuir isotherm was theoretically 
developed by Irving Langmuir in 1916 and portrays favorable adsorption. Because the Langmuir 
equation was developed assuming adsorption only occurs on a single layer of the sorbent, it often 
best fits gas adsorption data rather than liquid adsorption (Davis and Masten, 2009). However, an 
extension to the Langmuir isotherm model, the BET isotherm, was developed by Brunauer, 
Emmett, and Teller in 1938 to account for multi-layer adsorption on sorbents (Droste, 1997). The 
appropriate isotherm model to use must be found by comparing the behavior of each to 
adsorption data and selecting the best-fitting equation. Using that isotherm, the expected removal 
can be found for any ending concentration. The Langmuir equation is shown in Equation (2). 
       
   
     
      (2) 
In the Langmuir equation, qe is the ending loading rate, and qmax is the maximum possible 
loading rate, which is typically equal to qe for single-layer adsorption. Ce is the ending 
concentration, and K is the linearized equilibrium constant.  
2.5 Summary 
 As one of the most prescribed antibiotics in the world, SMX occurs frequently in 
wastewater and, by extension, water supplies and sediments. Studies show that its extensive use 
has triggered bacterial resistance, genetic mutations, and ecological disruption in naturally-
occurring organisms. Current treatment technologies, including AOPs, photolysis, and GAC 
adsorption, show evidence of some removal of SMX. However, the antimicrobial is not 
completely removed by WWTPs, causing further environmental occurrence and risk. 
  
17 
 
Chapter 3: Methodology 
This section will serve to outline all general laboratory procedures pertaining to the 
analysis of GAC and ion-exchange resins in the removal of SMX. Amberlite XAD4, Marathon 
C, Optipore L493, and pure SMX were purchased from Sigma-Aldrich Co. LLC. Available 
Filtrasorb 200 was received from Calgon Carbon Corporation. Tests were performed at pH levels 
of 5, 7, and 9 in order to simulate typical water and wastewater treatment processes.   
3.1 Sample Preparation 
 Solutions of known initial concentrations of Fluka® Brand SMX in Barnstead E-Pure 
water (ROpure ST Reverse Osmosis/tank system, Thermo Scientific) were prepared for each 
treatment procedure. Fixed amounts of SMX were weighed using a Mettler Toledo (AB104-S) 
scale and added to E-Pure water. Solutions were protected from light and continuously stirred 
with a magnetic stirrer for at least 24 hours prior to experimental use. Separate solutions for each 
pH level of 5, 7, and 9 were adjusted by the drop-wise addition of NaOH or HCl and measured 
with an Accumet Basic AB 15 (Fisher Scientific) pH meter. 
3.2 Measuring Sample Absorbance 
 In order to measure the amount of SMX removed during adsorption, the initial and final 
concentrations of SMX were determined before and after each trial. A Varian-Cary 50 UV-
visible spectrophotometer operated at a wavelength of 257 nm was used with Fisherbrand® 
Suprasil quartz 3-mL (10x10x45mm) cuvettes to measure sample absorbance. 
3.3 Sulfamethoxazole Concentration Standard Curves with Detection Limit 
 Standard concentration curves at pH 5, 7, and 9 were created with samples of known 
aqueous SMX concentrations in order to determine unknown concentrations of treated samples. 
Aqueous solutions of SMX at each pH and five known concentrations, ranging from 0.125 mg/L 
to 50 mg/L, were measured for absorbance by the Varian-Cary 50 Scan UV-visible 
spectrophotometer. Standard concentration curves for each pH level were then developed using 
the relationship between known sample concentration and the absorbance readings. Detection 
limits were established using the Student’s t-test statistical calculations in Microsoft Excel for 
the purpose of finding the point at which no statistical difference exists between a blank sample 
and SMX. 
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3.4 Adsorption Treatment 
 Adsorption treatment experiments were executed for analyzing the removal efficiency of 
specific adsorbent types on SMX. Adsorbents included one GAC, Filtrasorb 200, and three ion-
exchange resins, Amberlite XAD4, Marathon C, and Optipore L493. Prior to experiments, 
Marathon C required a rinse with E-Pure so that impurities in the resin could be removed and an 
appropriate pH could be maintained. In order to effectively analyze removal efficiency, 
adsorption was tested in a series of equilibrium and kinetics trials. Equilibrium trials measured 
the ending concentration at which the accumulation of SMX on resin surfaces ends and the rate 
of adsorption equals the rate of desorption. The rates of adsorption for each resin were assessed 
with kinetics trials. 
 For each treatment experiment, fixed amounts of adsorbent were weighed and added to 
42 mL amber glass vials. 10-mL volumes of solution were added to each vial, capped and placed 
into a rotisserie mixer for the purpose of continuous, uniform mixing and motion. Following 
treatments, each sample was removed from the rotisserie and centrifuged in an Eppendorf 
Centrifuge 5804 for 20 to 30 minutes at 2680 rpm, the highest velocity at which no damage 
could occur to the vials. Supernatant liquid was then decanted with a pipette into glass vials for 
analysis. 
3.4.1 Adsorption Equilibrium Trials 
 For maximum adsorption of SMX, equilibrium trials were performed over a 48-hour 
contact period. Equilibrium trials were conducted in pH series, all of which had a range of initial 
concentrations and a fixed amount of adsorbent. Initial concentrations of aqueous SMX were 10, 
20, 30, 40 and 50 mg/L. Solutions were added to vials containing approximately 0.2 g of 
adsorbent. After treatment and decantation, the pH was measured and corrected to the initial pH. 
Adjusted samples were then pipetted into cuvettes and measured for absorbance in the UV-
visible spectrophotometer. The final concentration of the sample was then calculated using the 
final absorbance value and calibration curves to the corresponding pH. 
3.4.2 Adsorption Kinetics Trials 
 The adsorption kinetics was assessed with series of time trials at intervals of 6, 12, 24, 
and 48 hours for each pH level (5, 7, 9). Solutions with initial concentrations of 10, 20, 30, 40 
and 50 mg/L were added to vials containing 0.2 g of adsorbent. Following treatment, samples 
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were centrifuged and decanted into glass vials. The pH was measured and corrected to the initial 
pH. Samples were then analyzed by the spectrophotometer for absorbance and the corresponding 
final concentration. 
  
20 
 
Chapter 4: Results and Discussion 
The aim of this study was to evaluate the removal of SMX from water at pH 5, 7, and 9 
by adsorption to GAC and by ion exchange sorption to polymeric resins. The data obtained from 
experimental tests were analyzed for the purpose of comparing the removal effectiveness of ion 
exchange resins and activated carbon on SMX. In addition, the parameters calculated from the 
data helped to determine a potential removal system for a small pharmaceutical manufacturer. 
All raw experimental data is presented in Appendix B. 
4.1 Calibration Curves 
In order to determine the final concentration of SMX after treatment, calibration curves 
were constructed for each pH tested. Known concentrations of SMX were analyzed for 
absorbance using the UV spectrometer, which was set at a wavelength of 257 nm, the 
wavelength at which SMX displayed the highest peak in absorption spectra. The three calibration 
curves are presented in Figure 7. 
 
 
Figure 7: Calibration Curves for SMX at pH 5, 7, and 9 
 All curves displayed fractions of variance (R
2
) above 0.998, indicating accurate 
detections below concentrations of 50 mg/L. Although similar in slope, the curves differed 
slightly as a result of the change in molecular charge when pKa values were reached. At pH 5, 
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the neutral form of SMX is dominant. At pH levels higher than 5.6, the molecule becomes 
deprotonated on its amine group. As the pH increases, a higher fraction of anionic SMX species 
exists compared to that of its neutral form. 
4.2 Adsorption Isotherms 
Isotherms were established in order to model and assess the adsorption behavior at 
equilibrium. Final concentration readings from equilibrium trials were calculated using the 
calibration curves. The ending concentrations were then used to generate isotherm curves for 
each resin. Values were compared and contrasted to Langmuir and Freundlich models to find the 
best fit. Between the two adsorption isotherm models, the Freundlich model best fit the data for 
each resin. As shown in all equilibrium data, AMB was not successful in removing SMX, likely 
due to lack of proper rinsing before application. 
4.2.1 Equilibrium at pH 5 
 
 
Figure 8: Equilibrium data for all adsorbents, pH 5 
 
Figure 8 displays the equilibrium data for all adsorbents at pH 5. OPT and FS-200 had 
the highest adsorption capacity at this pH, followed by that of MAR and AMB. At this pH, the 
majority of SMX is in neutral form, enabling maximum adsorption to activated carbon and non-
ionic polymeric resins. The high acidity of MAR may have attributed to its poor adsorption of 
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SMX at this pH, since the concentration of H
+
 competes with the functional groups of MAR. 
Additionally, the neutral form of SMX has no ions to exchange with MAR. The following 
Freundlich isotherm equations model the equilibrium relationships of each adsorbent at pH 5: 
 
FS-200:             
      
       (3) 
AMB:             
      
      (4) 
MAR:             
      
      (5) 
OPT:             
      
      (6) 
 
4.2.2 Equilibrium at pH 7 
 
 
Figure 9: Isotherms for all adsorbents, pH 7 
 
 Equilibrium tests at pH yielded the most efficient adsorption capacities among all the 
adsorbents. Out of all, OPT and MAR had the highest adsorption rates, which may be a result of 
the higher number of anionic SMX species present. The isotherms for all adsorbents at this pH 
are shown in Figure 9. When the pH level is about 7, the SMX molecule exists as both neutral 
and anionic, with the anionic species being dominant. The anionic form of SMX was more likely 
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to be attracted to the hydrophobic surface of OPT. This adsorption was amplified by the 
extensive pore surface area of OPT. Again, the Freundlich isotherm model closely fit the 
equilibrium data for pH 7. The following equations were generated: 
 
FS-200:             
      
       (7) 
AMB:             
      
      (8) 
MAR:             
      
      (9) 
OPT:            
      
      (10) 
 
4.2.3 Equilibrium at pH 9 
 
 
Figure 10: Equilibrium data for all adsorbents, pH 9 
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to FS-200. The isotherms generated for all adsorbents at pH 9 are displayed in Figure 10. 
Equations 11 through 14 show the Freundlich isotherms for each adsorbent at pH 9.  
 
FS-200:            
      
      (11) 
AMB:             
      
      (12) 
MAR:             
      
      (13) 
OPT:             
      
      (14) 
 
4.3 Adsorption Kinetics 
Kinetics tests were necessary for further evaluating the reactions over time. The kinetics 
trials showed that the most adsorption occurred within the first six hours of testing, regardless of 
pH. Equilibrium was reached between 12 and 24 hours, as shown in Figures 11, 12, and 13. This 
validated the use of 48-hour trials as equilibrium trials because all adsorption had reached 
equilibrium by that time. In addition, the following graphs illustrate that pH levels between 5 and 
9 do not significantly affect the rate of adsorption. 
 
 
Figure 111: Adsorption Kinetics at pH 5 
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Figure 12: Adsorption Kinetics at pH 7 
 
 
Figure 13: Adsorption Kinetics at pH 9 
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Chapter 5: Conclusions and Recommendations 
In this project, ion exchange was proven to be an effective method for the removal of 
SMX from water. However, not all adsorbents were equally effective, as dictated by differences 
in chemical structures. The most efficient resins of the four tested were OPT and FS-200. Should 
future testing be performed, these experiments can be expanded by considering other methods of 
treatment or more extensive testing on these adsorbents. For example, proper pretreatment and 
regeneration of the adsorbents should be examined, and filtration of the tested samples should be 
considered for all adsorption results. By investigating these additional parameters, a larger-scale 
operation or the use of columns could be utilized and more properly evaluated. 
5.1 Removal System Design 
The experimental procedures used in this project employed laboratory bench-scale 
contact vials to determine equilibrium loading rates. The resulting data were used to develop a 
small-scale industrial design for a batch reactor intended to remove SMX from wastewater. 
Specifically, a half-sized system was designed for an arbitrary manufacturing plant that produces 
SMX to treat wastewater effluent for the antibiotic. In a manufacturing plant, products are 
susceptible to occurring in wastewater due to equipment washing and general waste discharge. A 
design such as this would prevent excessive SMX from being discharged into the environment. 
This design can also be repurposed for other applications, such as a small-scale package 
wastewater treatment plant. The proposed sequencing batch reactors (SBRs) closely model the 
experimental procedures utilized in this project, since SBRs maximize contact between adsorbent 
and contaminated water. The equilibrium loading rates determined in Chapter 4 were used to 
find the optimum volume of adsorbent for target removal of SMX from waste effluent. 
 A few notes bear mention to accompany this design. This proposed system was designed 
to be half the size of a typical system for real applications. This is because experimental results 
did not yield enough information to determine other parameters for full-scale operation. 
Additionally, other conditions may change when expanding the system size. For example, the 
theoretical amount of adsorbent may not be equal to the necessary mass of adsorbent.  
The design itself is based on factory operations spanning an eight-hour workday and on 
an effluent wastewater discharge rate of 5,000 gallons per day. The initial concentration of SMX 
in the water was taken to be 0.05 mg/L, and the target effluent concentration was 0.00001 mg/L, 
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a value corresponding to the MIC of a common soil bacteria family, Pseudomonas (Qin 2012). 
The adsorbent that would be used is OPT, since it was successful in the removal of SMX and has 
characteristics that correlate to optimal adsorption. These characteristics include high surface 
area, an applicable range of pore sizes, and a high loading rate capacity. To achieve this removal, 
the total mass of OPT needed was 54,000 kg. This design incorporated four main operating tanks 
with one offline back-up tank, all holding a maximum volume of 400 gallons. A schematic of the 
reactors in parallel is shown in Figure 14. 
 
 
 
5.1.1 Process 
The proposed system calls for five sequencing batch reactors operating in parallel. Four 
are designed to operate simultaneously with one offline as needed. Each tank ensures full contact 
between 313.5 gallons of contaminated water and 10,400 kg of adsorbent over the span of six 
hours. Vessels would be constructed from A36 steel, a type of carbon steel alloy. To minimize 
the cost of materials, a height-diameter aspect ratio of 2:1 was chosen for the tanks. The pH of 
the water being treated would be monitored and maintained with a separate system containing a 
pH probe and applicators for acid and base injection. A schematic of one batch reactor from the 
prospective design is shown in detail in Figure 15. 
At the beginning of operation, freshly regenerated adsorbent is fed into the bottom of the 
tank. The feed at the top of the reactor delivers contaminated water, which the tank mixes for six 
hours. The high crushing capacity of OPT allows it to be mixed at a moderate speed without 
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Figure 14: Schematic of SBRs 
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risking damage to the resin. The solution is then allowed to settle before the water is decanted by 
an outlet pipe located above the settled adsorbent bed. After the water has exited the tank, a 
water wash stream is fed into the tank to ensure that all adsorbent beads are removed. The 
adsorbent beads are removed through the outlet at the bottom of the tank and piped to a steam 
regeneration tank. Meanwhile, the reactor is refilled with previously regenerated adsorbent and 
the process begins once more. This occurs simultaneously in each tank in order to treat all 
effluent flow throughout the day.  
 
Figure 15: Schematic of one SBR in parallel 
 
5.2 Future Recommendations 
The tests performed over the course of this project did not comprehensively evaluate all 
treatment and regeneration options. Methods of adsorbent regeneration and recycled adsorbent 
efficiency were not investigated. This should be studied in greater detail to determine the best 
regeneration process for a particular adsorbent. Additionally, it would be prudent to further study 
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the use of these adsorbents on other polar organic contaminants (POCs). This would compare the 
removal of SMX to that of other organics and would aid plants such that they could remove 
multiple contaminants with one process. 
When developing the design portion of this report, it was noted that the use of columns 
may dramatically improve process efficiency. The amount of necessary adsorbent would be 
reduced due to the occurrence of equilibrium adsorption in a moving zone across the column 
(Droste, 1997). Contaminated water can be recycled through the column multiple times. While 
column studies were not performed during experimentation, they are highly suggested for future 
testing. It is also recommended that further experiments study lower concentrations of 
contaminants in water. The use of an HPLC would allow for accurate measurements at such low 
concentrations. With improvements in technology and a better understanding of the behavior of 
POCs and their removal, there can be healthier ecosystems and water supplies in the future.  
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Appendix A: List of Abbreviations 
 
AMB – Amberlite® XAD4 
AOP – Advanced Oxidation Process 
EDC – Endocrine Disrupting Compound 
FS-200 – Filtrasorb® 200 
GAC – Granular Activated Carbon 
MAR – DOWEX® Marathon® C 
MIC – Minimum Inhibitory Concentration 
OPT – Optipore® L493 
PAC – Powdered Activated Carbon 
PhAC – Pharmaceutically Active Compound 
POC – Polar Organic Compound or Polar Organic Contaminant 
PPCP – Pharmaceutical and Personal Care Products 
SBR – Sequencing Batch Reactor 
SMX – Sulfamethoxazole 
STP – Standard Temperature and Pressure 
TMP – Trimethoprim 
US EPA – United States Environmental Protection Agency 
US FDA – United States Food and Drug Administration 
WTP – Water Treatment Plant 
WWTP – Wastewater Treatment Plant 
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Appendix B: Experimental Data 
Calibration Curves 
Table 1: Calibration Curves of SMX at pH 5, 7, and 9 
Measured Concentration 
of SMX (mg/L) 
pH Absorbance 
pH 5 Series 
50.000 5.05 2.7470 
30.000 5.02 1.7325 
20.000 5.04 1.1137 
15.000 4.97 0.8223 
10.000 4.94 0.5348 
pH 7 Series 
32.000 6.87 2.0760 
8.000 6.98 0.5117 
2.000 7.10 0.1621 
0.500 6.94 0.0359 
0.125 6.93 0.0127 
pH 9 Series 
50.000 8.96 2.8939 
40.000 8.94 2.2804 
30.000 9.03 1.7222 
20.000 8.94 1.1672 
10.000 8.95 0.5865 
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Example T-test Calculation 
SMX Concentration 
(mg/L) 
Zero 
(blank) 
10 5 1 0.5 0.1 0.05 
Absorbance 
-0.0014 0.4741 0.2509 0.0491 0.0230 0.0030 -0.0003 
-0.0019 0.4758 0.2524 0.0491 0.0235 0.0020 0.0001 
-0.0015 0.4762 0.2553 0.0505 0.0239 0.0019 -0.0006 
-0.0009 0.4759 0.2551 0.0495 0.0239 0.0020 -0.0013 
-0.0018 0.4766 0.2556 0.0498 0.0250 0.0029 -0.0013 
 
t-Test: Paired Two Sample for Means 
   
  Variable 
1 
Variable 
2 
Mean -0.0015 -0.00068 
Variance 1.55E-07 3.82E-07 
Observations 5 5 
Pearson Correlation -0.472607  
Hypothesized Mean Difference 0  
df 4  
t Stat -2.093636  
P(T<=t) one-tail 0.0522005  
t Critical one-tail 2.1318468  
P(T<=t) two-tail 0.1044009  
t Critical two-tail 2.7764451   
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Adsorption Equilibrium (48-hour) Data 
Amberlite XAD4 
Table 2: Amberlite XAD4 Isotherm Data, pH 5 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.2001 5.00 9.66 4.96 10 0.1856 3.31 66.9 0.33 
0.1982 5.03 9.50 5.02 20 0.4144 7.43 62.9 0.63 
0.2018 5.04 9.36 4.98 30 0.6712 12.1 59.8 0.89 
0.2005 4.99 8.92 4.98 40 0.7535 13.5 66.2 1.32 
0.2019 5.05 9.62 4.93 50 0.9100 16.4 67.3 1.67 
 
Table 3: Amberlite XAD4 Isotherm Data, pH 7 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1995 6.95 9.61 7.04 10 0.4157 6.29 37.1 0.19 
0.1996 6.98 9.42 7.04 20 0.6400 9.77 51.2 0.51 
0.2000 6.96 9.74 7.03 30 0.7431 11.4 62.1 0.93 
0.2003 6.99 9.78 7.05 40 1.1269 17.3 56.7 1.13 
0.2008 6.97 9.77 7.02 50 1.1941 18.4 63.3 1.58 
0.2005 6.96 9.85 6.91 10.5 0.2722 4.07 61.2 0.32 
0.2001 7.03 9.49 6.97 15 0.4554 6.91 53.9 0.40 
0.2000 6.96 9.79 6.91 32 0.9311 14.3 55.4 0.89 
0.1995 6.96 9.80 6.99 35 0.9769 15.0 57.2 1.00 
0.1998 6.98 9.85 7.01 38 0.6366 9.72 74.4 1.42 
 
Table 4: Amberlite XAD4 Isotherm Data, pH 9 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1966 9.02 8.97 8.96 10 0.2393 3.97 60.3 0.31 
0.1967 9.02 9.83 9.00 20 0.4423 7.52 62.4 0.63 
0.2005 9.00 9.85 8.94 30 0.6665 11.4 61.9 0.93 
0.1976 9.06 9.86 8.98 40 0.9435 16.3 59.3 1.20 
0.1975 8.94 9.89 8.99 50 1.2853 22.2 55.5 1.41 
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Adsorption Equilibrium (48-hour) Data 
Marathon C 
Table 5: Marathon C Isotherm Data, pH 5 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1992 5.01 3.48 4.93 10 1.4614 26.3 -162.9 -0.82 
0.1992 5.00 3.44 5.01 20 1.5831 28.5 -42.4 -0.43 
0.2009 5.01 3.49 4.97 30 1.6256 29.2 2.5 0.04 
0.2009 5.00 3.41 5.01 40 1.6840 30.3 24.3 0.48 
0.1988 5.04 3.46 4.95 50 1.6514 29.7 40.6 1.02 
0.2003 4.91 4.06 5.04 10 0.0853 1.50 85.0 0.42 
0.1990 4.94 3.59 4.98 20 0.1875 3.34 83.3 0.84 
0.1992 4.96 4.30 4.99 30 0.0510 0.88 97.1 1.46 
0.1981 4.92 4.03 5.01 40 0.1750 3.12 92.2 1.86 
0.1998 5.00 3.91 5.04 50 0.1787 3.18 93.6 2.34 
*Data displayed in italicized font indicates unwashed resin 
 
Table 6: Marathon C Isotherm Data, pH 7 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1989 6.99 3.52 6.95 10 1.4618 22.51 -125.1 -0.63 
0.2000 6.96 3.45 6.92 20 1.6474 25.39 -27.0 -0.27 
0.1994 6.96 3.46 7.03 30 1.5653 24.12 19.6 0.3 
0.1994 6.97 3.52 7.03 40 1.5434 23.78 40.6 0.81 
0.1995 7.01 3.49 6.93 50 1.6010 24.67 50.7 1.27 
0.1991 6.98 2.88 6.95 10 0.0943 1.31 86.9 0.44 
0.1955 6.94 4.73 6.98 20 0.0619 0.81 96.0 0.98 
0.2045 6.99 4.61 6.94 30 0.0817 1.11 96.3 1.41 
0.1972 6.96 4.14 6.94 40 0.0912 1.26 96.9 1.96 
0.1960 6.95 4.24 6.93 50 0.1010 1.41 97.2 2.48 
*Data displayed in italicized font indicates unwashed resin 
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Adsorption Equilibrium (48-hour) Data 
 
Marathon C (Continued) 
Table 7: Marathon C Isotherm Data, pH 9 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1996 8.99 3.47 9.01 10 1.4750 25.55 -155.5 -0.78 
0.2000 8.94 3.63 9.03 20 1.8516 32.12 -60.6 -0.61 
0.2002 9.05 3.40 8.99 30 1.7960 31.15 -3.8 -0.06 
0.1997 9.00 3.36 8.96 40 1.8639 32.34 19.2 0.38 
0.2000 8.94 3.45 9.01 50 1.8338 31.81 36.4 0.91 
0.2044 9.05 4.67 9.03 10 0.0978 1.50 85.0 0.42 
0.2009 9.01 4.24 9.01 20 0.0696 1.01 95.0 0.95 
0.1991 9.00 4.19 9.02 30 0.0761 1.13 96.2 1.45 
0.1992 9.03 4.00 8.95 40 0.0944 1.44 96.4 1.94 
0.1979 9.01 3.93 8.95 50 0.1037 1.61 96.8 2.45 
*Data displayed in italicized font indicates unwashed resin 
 
Optipore L493 
Table 8: Optipore L493 Isotherm Data, pH 5 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1991 4.94 4.64 4.99 8 0.0161 0.26 96.8 0.39 
0.2012 5.01 4.78 5.04 10 0.0210 0.34 96.6 0.48 
0.2004 5.04 4.12 4.95 15 0.0090 0.13 99.1 0.74 
0.2007 5.00 4.67 5.03 20 0.0194 0.31 98.5 0.98 
0.1996 5.05 5.52 5.01 25 0.0449 0.77 96.9 1.21 
0.2004 5.01 4.59 4.95 30 0.0237 0.39 98.7 1.48 
0.2001 5.06 4.63 5.03 35 0.0141 0.22 99.4 1.74 
0.1983 5.00 4.51 4.92 40 0.0297 0.50 98.8 1.99 
0.1993 5.04 4.50 4.90 50 0.0259 0.43 99.1 2.49 
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Adsorption Equilibrium (48-hour) Data 
 
Optipore L493 (Continued) 
Table 9: Optipore L493 Isotherm Data, pH 7 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.2003 6.99 4.90 6.96 10 0.0704 0.94 90.6 0.45 
0.2009 6.96 5.45 6.99 20 0.0251 0.24 98.8 0.98 
0.1984 6.97 6.23 6.94 40 0.0354 0.40 99.0 2.00 
0.2000 6.96 5.85 6.95 30 0.0406 0.48 98.4 1.48 
0.1993 7.01 6.38 6.94 50 0.0541 0.69 98.6 2.47 
 
Table 10: Optipore L493 Isotherm Data, pH 9 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1997 9.02 6.25 8.98 10 0.1332 2.12 78.8 0.39 
0.2000 9.02 7.54 8.97 20 0.1071 1.67 91.7 0.92 
0.1995 9.00 7.47 9.05 30 0.0858 1.29 95.7 1.44 
0.2001 9.06 7.26 8.98 40 0.1493 2.40 94.0 1.88 
0.1995 8.94 7.73 9.00 50 0.1782 2.91 94.2 2.36 
0.2005 9.06 8.68 9.04 8 0.0803 1.20 85.0 0.34 
0.1993 8.95 8.50 8.98 15 0.0647 0.93 93.8 0.71 
0.1995 8.94 8.66 8.93 25 0.1156 1.81 92.8 1.16 
0.2006 9.00 8.40 8.98 35 0.1379 2.20 93.7 1.63 
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Adsorption Equilibrium (48-hour) Data 
Filtrasorb 200 
Table 11: Filtrasorb 200 Isotherm Data, pH 5 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.2018 5.00 6.34 5.04 10 0.0241 0.40 96.0 0.48 
0.2028 5.03 5.94 5.01 20 0.0305 0.51 97.5 0.96 
0.1998 5.04 7.01 4.93 30 0.0591 1.03 96.6 1.45 
0.1998 4.99 6.06 4.95 40 0.0141 0.22 99.5 1.99 
0.2001 5.05 7.22 4.97 50 0.0144 0.22 99.6 2.49 
0.1996 4.94 6.07 4.93 8 0.0052 0.06 99.3 0.4 
0.1996 5.04 6.11 4.96 15 0.0104 0.15 99.0 0.74 
0.2000 5.05 6.10 5.02 25 0.0079 0.11 99.6 1.24 
0.2008 5.06 6.15 5.01 35 0.0036 0.03 99.9 1.74 
0.1996 4.94 6.07 4.93 8 0.0148 0.23 97.1 0.39 
0.1996 5.04 6.11 4.96 15 0.0066 0.08 99.5 0.75 
0.2000 5.05 6.10 5.02 25 0.0053 0.06 99.8 1.25 
0.2008 5.06 6.15 5.01 35 0.0071 0.09 99.7 1.74 
 
Table 12: Filtrasorb 200 Isotherm Data, pH 7 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1995 6.95 8.07 7.02 10 0.1376 1.98 80.2 0.4 
0.2005 6.96 7.34 6.95 10.5 0.0056 0.07 99.3 0.52 
0.1998 7.03 7.16 7.16 15 0.0437 0.53 96.5 0.72 
0.1996 6.98 8.48 7.08 20 0.0872 1.20 94.0 0.94 
0.2000 6.96 9.24 7.04 30 0.1924 2.83 90.6 1.36 
0.2001 6.96 7.10 7.10 32 0.1902 2.80 91.3 1.46 
0.2003 6.96 7.30 7.11 35 0.1654 2.41 93.1 1.63 
0.1997 6.98 7.21 7.01 38 0.1719 2.51 93.4 1.78 
0.2003 6.99 9.50 7.03 40 0.1754 2.57 93.6 1.87 
0.2008 6.97 9.76 7.01 50 0.2486 3.70 92.6 2.31 
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Adsorption Equilibrium (48-hour) Data  
 
Filtrasorb 200 (Continued) 
Table 13: Filtrasorb 200 Isotherm Data, pH 9 
Mass of 
Adsorbent 
(g) 
Starting 
pH 
Ending 
pH 
Adjusted 
pH 
Ci 
(mg/L) 
Abs 
(A) 
Ce 
(mg/L) 
% 
Decrease 
Qe 
(mg/g) 
0.1985 8.92 7.16 8.98 10 0.0171 0.10 99.0 0.5 
0.1993 9.06 6.41 9.01 8 0.0037 -0.14 101.8 0.41 
0.1994 8.95 7.85 8.97 15 0.0092 -0.04 100.3 0.75 
0.1993 9.04 8.47 8.95 20 -0.0022 -0.24 101.2 1.02 
0.1991 8.94 3.25 8.93 25 0.0935 1.43 94.3 1.18 
0.1987 8.98 8.40 8.97 30 0.0015 -0.18 100.6 1.52 
0.1992 9.00 8.72 9.03 35 0.035 0.41 98.8 1.74 
0.1995 8.94 8.35 8.94 40 0.0439 0.56 98.6 1.98 
0.2002 8.94 8.42 8.96 50 0.0062 -0.09 100.2 2.5 
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Adsorption Kinetics Data 
Table 14: Amberlite XAD4 Kinetics Data 
pH 
series 
Conci (mg/L) 
Time 
(hours) 
pHi pHf Concf (mg/L) 
5 
50 0 5.03 4.96 50 
50 6 5.03 4.95 20.71 
50 12 5.05 4.96 21.31 
50 24 5.00 5.05 20.24 
50 48 5.05 4.93 16.36 
7 
50 0 7.01 7.01 50 
50 6 7.04 6.95 20.11 
50 12 7.03 6.95 19.45 
25 24 6.99 6.96 8.56 
50 48 6.97 7.02 18.36 
9 
50 0 9.01 9.03 50 
50 6 9.01 9.03 25.77 
50 12 8.96 8.98 22.50 
50 24 8.95 9.02 22.07 
50 48 8.94 8.99 22.24 
 
Table 15: Marathon C Kinetics Data 
pH 
series 
Conci (mg/L) 
Time 
(hours) 
pHi pHf Concf (mg/L) 
5 
50 0 5.04 5.03 50 
50 6 5.04 5.03 2.38 
50 12 5.02 5.00 1.57 
50 24 5.00 4.98 1.50 
50 48 5.00 5.04 3.18 
7 
50 0 7.01 7.08 50 
50 6 7.01 7.08 2.24 
50 12 6.95 6.97 2.08 
50 24 6.95 7.00 1.62 
50 48 6.95 6.93 1.41 
9 
50 0 9.00 8.98 50 
50 6 9.00 8.98 2.95 
50 12 8.97 8.97 2.09 
50 24 9.01 8.99 1.67 
50 48 9.01 8.95 1.61 
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Adsorption Kinetics Data 
Table 16: Optipore L493 Kinetics Data 
pH 
series 
Conci (mg/L) 
Time 
(hours) 
pHi pHf Concf (mg/L) 
5 
50 0 5.04 4.98 50 
50 6 5.04 4.98 0.74 
50 12 5.01 4.94 -0.22 
50 24 4.99 4.98 0.43 
50 48 5.04 4.90 0.43 
7 
50 0 7.01 6.95 50 
50 6 7.01 6.95 0.11 
50 12 6.94 6.97 0.45 
50 24 7.02 7.00 1.10 
50 48 7.01 6.94 0.69 
9 
50 0 9.00 9.04 50 
50 6 9.00 9.04 2.22 
50 12 8.97 9.01 1.68 
50 24 8.95 8.95 1.57 
50 48 9.00 8.98 2.91 
 
Table 17: Filtrasorb 200 Kinetics Data 
pH 
series 
Conci (mg/L) 
Time 
(hours) 
pHi pHf Concf (mg/L) 
5 
50 0 5.03 5.05 50 
50 6 5.03 5.05 -0.02 
50 12 5.05 5.02 0.32 
50 24 5.00 5.01 0.61 
50 48 5.05 4.97 0.22 
7 
50 0 7.04 7.01 50 
50 6 7.04 7.01 -0.09 
50 12 7.03 7.03 0.16 
25 24 6.99 6.95 0.10 
50 48 6.97 7.01 3.70 
9 
50 0 9.01 9.03 50 
50 6 9.01 9.03 0.09 
50 12 8.96 8.93 -0.12 
50 24 8.95 8.91 -0.06 
50 48 8.94 8.96 -0.09 
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Appendix C: Design Calculations 
Mass of OPT 
Qe=5.1558x10
-6
 ( mg SMX/g Optipore); Q0= 0 mg/g 
C0=0.05 mg/L SMX; Ce=0.00001 mg/L SMX 
B= Mass of Optipore needed 
Q=5,000 gallons/day  Q=209 gal/h=791 L/h 
 
       
 
 
    
         
 
                  
                 
  
 
                 
                
            
 
Volume of tank 
Q=5,000 gal/day = 209 gal/h;  t= 6 h 
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Appendix D: Product Information Sheets 
Filtrasorb® 200 – Calgon Carbon Corporation 
 
Figure 16: FS-200 Data Sheet (Calgon Carbon Corporation, 2013) 
46 
 
Amberlite® XAD4 – Dow Chemical Company 
 
Figure 17: Amberlite XAD4 Product Information Sheet (Dow Chemical Company, 2013) 
47 
 
Marathon® C – Dow Chemical Company 
 
Figure 18: Marathon C Product Data Sheet (Dow Chemical Company, 2013) 
48 
 
Optipore® L493 – Dow Chemical Company 
 
Figure 19: Optipore L493 Product Information Sheet p. 1 (Dow Chemical Company, 2013) 
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Figure 20: Optipore L493 Product Information Sheet p. 2 (Dow Chemical Company, 2013) 
